YS43-22

(4S,4aS,5aS,13aS,15aS,15bR)-6-methyl-3,4,4a,5,5a,7,8,13a,15,15a,15b,16-dodecahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinoline-6-ium-14-one,chloride

21α,22-Dihydrostrychnidine

19,22-Dimethyltetracontan

SF-22 (TRPML3 activator)

7,22-dihydro-8,21-dioxa-tetranaphtho[2,1-b:1',2'-d:2'',1''-h:1''',2'''-j]cyclododecene

Ergosten-(22)-triol-(3α,5α,8α)

4-((Cyclohexylamino)methyl)benzoic acid hydrochloride

1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine

2-Methoxy-6-(pyrazol-1-yl)-benzonitrile

3-Bromo-6-nitro-2(1h)-quinolinone

1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-

(4-Methyl-tetrahydro-furan-2-yl)-methanol

Methyl 3-[(5-chloro-2-methoxyphenyl)sulfonyl]-2,3-dihydro-7-methyl-5-benzoxazolecarboxylate

N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide

4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde

2-methyl-N-(pyridin-2-ylmethyl)prop-2-en-1-amine